EClinCloud Invites You to the 2025 CMAC Annual Conference to Discuss AI + eCOA Enabling Clinical Trials

Source: EClinCloud. Author: EClinCloud.
From March 18 to 20, EClinCloud will appear at the 2025 CMAC Annual Conference, and we invite colleagues across the pharmaceutical industry to gather and discuss how eCOA enables clinical trials and frontier applications of AI technology.

Presentations and Roundtable Discussions

Su Quanyu
Co-Founder and Chief Commercial Officer, EClinCloud
Sub-forum:
Electronic Clinical Outcome Assessment (eCOA): DCT Elements with Vast Potential and Practical Implementation
Time and Venue:
March 19, 9:20–9:40, 2nd Floor, Room A211
Keynote Presentation:
"Crossing Boundaries, Addressing Core Needs: eCOA Enabling Clinical Trials"
Time and Venue:
March 19, 11:15–12:00, 2nd Floor, Room A211
Roundtable Discussion:
"Challenges and Strategies in the Localized Application of eCOA/ePRO"
Booth Activities: B27
Check in at the EClinCloud booth on-site to receive a gift

Conference Information

Image source: CMAC
Conference Dates: March 18–20
Venue: Suzhou International Expo Center
Conference Agenda:

Scan the QR code to view the agenda
EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated intelligent clinical cloud platform and endpoint assessment technologies to provide global pharmaceutical companies and research institutions with technology products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services, creating efficient and precise digital solutions. Leveraging AI predictive models and an intelligent data platform, EClinCloud dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug and medical device R&D cycles for the benefit of patients.



